NINDS | Technology Transfer

Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Cyprus
09795720.3
Filed on 2009-12-18

Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Switzerland
09795720.3
Filed on 2009-12-18

Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Bulgaria
09795720.3
Filed on 2009-12-18

Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Belgium
09795720.3
Filed on 2009-12-18

Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Read more about Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis

Austria
09795720.3
Filed on 2009-12-18

Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS)

Read more about Deuterated 3,4-Dihydroxyphenylserine (Deuterated L-DOPS)

US Application 16/000,965
Filed on 2018-06-06

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

Read more about METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

US Application 16/132,852
Filed on 2018-09-17

11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists

Read more about 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists

Ireland
14750663.8
Filed on 2016-01-22

11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists

Read more about 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists

United Kingdom
14750663.8
Filed on 2016-01-22

11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists

Read more about 11-OXO-10,11-Dihydrodibenzo[B,F][1,4]Thiazepine S-Oxide Derivatives And Their Use As Dopamine D2 Receptor Antagonists

France
14750663.8
Filed on 2016-01-22

Subscribe to NINDS